[Elsevier] Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial |
|
This post will be closed automatically in 2026-07-08 05:05
Reward30points
|
| |
50
[Full book]Nuclear and Radiochemistry 2nd Edition
10
Creation and Validation of the Select Medical Patient Reported Experience Measure for Physical and Occupational Therapy Outpatient Clinics
10
Impact of high versus low fraction of inspired oxygen for anaesthetic washout and extubation on postoperative pulmonary atelectasis formation and oxygenation: a randomised controlled trial
30
Ketosis-Prone Type 2 Diabetes Mellitus: 3 Decades of Clinical, Pathophysiologic, and Therapeutic Insights
20
The Art of Estimating Cardiorespiratory Fitness
